Menu
Menu
🚀 We are proud to continue our expansion in the Middle East through our collaboration with National Reference Laboratory (NRL), a leader in pathology and one of the largest CAP-accredited laboratory networks in the region.
This partnership reflects a shared commitment to advancing data-driven cancer care and expanding access to genomic insights across the UAE.
As part of this collaboration, NRL has adopted MSK-IMPACT® powered with SOPHiA DDM™ — a decentralized, comprehensive genomic profiling solution co-developed with Memorial Sloan Kettering Cancer Center.
By integrating this cutting-edge application, NRL is expanding access to advanced, clinically relevant genomic insights across the UAE—enabling more informed decisions in cancer care through data-driven precision medicine.
🤝 We are honored to partner with NRL and look forward to the impact our collaboration will bring to data-driven medicine in the Middle East.
#PrecisionOncology #Genomics #UAEHealthcare #DataDrivenMedicine #Partnership #CancerCare
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
